MichelleDavisMD

General Gynecology, Gynecologic Oncology

Attending Physician Gynecologic Oncology

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2015 - 2018
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2011 - 2015
University of South Florida College of MedicineClass of 2011

PubMed

2 citations
Successful treatment of stage IVB ovarian carcinosarcoma with PARP Inhibitor: A case report.
Jessica D St Laurent, Mary Kathryn Abel, Joyce Liu, Bradley J Quade, Michelle R Davis
Gynecologic Oncology Reports. 2024-02-01
3 citations
Endometrial Cancer Risk Among Germline/Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
Kimia Sorouri, Filipa Lynce, Colleen M Feltmate, Michelle R Davis, Michael G Muto
JCO Precision Oncology. 2023-09-01
2 citations
Cervical Cancer Screening and Follow-Up Practices in U.S. Prisons.
Alexa N Kanbergs, Mackenzie W Sullivan, Morgan Maner, Lauren Brinkley-Rubinstein, Annekathryn Goodman
American Journal of Preventive Medicine. 2023-02-01

Journal Articles

Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women.
Feldman S, Cook E, Davis M, Gershman ST, Haas J, Perkins R., J Lower Genit Trac Dis, 10/2018
The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.
Davis M, Strickland K, Easter S, Worley M, Feltmate C, Muto M, Horowitz N, Berkowitz R, Feldman S., Gynecologic Oncology, 7/2018
Clinical outcomes of partial hydatidiform mole in the p57 era.
Soong TR*, Davis M*, Elias K, Horowitz N, Yuan L, Goldstein D, Berkowitz R**, Quade B**., Journal of Reproductive Medicine, 2018
Cervical Cancer Screening and the Immunosuppressed Patient: the Issues in Screening High-Risk Populations.
Davis M, Perkins R, Cain J, Feldman S., Current Obstetrics and Gynecology Reports, 10/13/2016
Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.
Elias K, Emori M, Westerling T, Long H, Budina-Kolomets A, Li F, MacDuffie E, Davis M, Holman A, Lawney B, Freedman M, Quackenbush J, Brown M, Drapkin R., JCI Insight, 8/18/2016
Join now to see all